Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.9100 (-2.75%) ($27.1400 - $28.9900) on Wed. Nov. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.91% (three month average) | RSI | 34 | Latest Price | $27.9100(-2.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.955% in a week (0% probabilities). IPO(-7%) TLT(-6%) VIXM(-5%) SLV(-5%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.955% (StdDev 3.91%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
1 - 5 Day Possible Target | $12.98(-53.49%) | Resistance Level | $30.9 | 5 Day Moving Average | $27.75(0.58%) | 10 Day Moving Average | $28.75(-2.92%) | 20 Day Moving Average | $30.9(-9.68%) | To recent high | -31.8% | To recent low | 4.9% | Market Cap | $550m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |